KDAGF (KDA Group) ROE %: -57.29% (As of Jan. 2026)


What is KDA Group ROE %?

KDA Group KDAGF ROE % is -57.29% as of Jan. 2026. The stock has 3 warning signs investors should review. Among 628 Healthcare Providers & Services companies, KDA Group ranks worse than 90.76% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. KDA Group's annualized net income for the quarter that ended in Jan. 2026 was $-3.91 Mil. KDA Group's average Total Stockholders Equity over the quarter that ended in Jan. 2026 was $6.83 Mil. Therefore, KDA Group's annualized ROE % for the quarter that ended in Jan. 2026 was -57.29%.

The historical rank and industry rank for KDA Group's ROE % or its related term are showing as below:

KDAGF' s ROE % Range Over the Past 10 Years
Min: -245.93   Med: -47.64   Max: 197.98
Current: -65.32

During the past 13 years, KDA Group's highest ROE % was 197.98%. The lowest was -245.93%. And the median was -47.64%.

KDAGF's ROE % is ranked worse than
90.76% of 628 companies
in the Healthcare Providers & Services industry
Industry Median: 5.72 vs KDAGF: -65.32

KDA Group  (OTCPK:KDAGF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jan. 2026 )
=Net Income/Total Stockholders Equity
=-3.912/6.828
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-3.912 / 0.42)*(0.42 / 6.84)*(6.84 / 6.828)
=Net Margin %*Asset Turnover*Equity Multiplier
=-931.43 %*0.0614*1.0018
=ROA %*Equity Multiplier
=-57.19 %*1.0018
=-57.29 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jan. 2026 )
=Net Income/Total Stockholders Equity
=-3.912/6.828
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-3.912 / -4.52) * (-4.52 / -4.46) * (-4.46 / 0.42) * (0.42 / 6.84) * (6.84 / 6.828)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8655 * 1.0135 * -1061.9 % * 0.0614 * 1.0018
=-57.29 %

Note: The net income data used here is four times the quarterly (Jan. 2026) net income data. The Revenue data used here is four times the quarterly (Jan. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


KDA Group ROE % Related Terms


KDA Group ROE % Historical Data

* Premium members only.

The historical data trend for KDA Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KDA Group ROE % Chart

KDA Group Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98.79 -237.83 198.04 -46.63 -68.96

KDA Group Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -63.98 -65.99 -88.39 -50.38 -57.29

KDAGF vs VEEV, BTSG, TEM: ROE % Comparison

For the Health Information Services subindustry, KDA Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KDA Group ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, KDA Group's ROE % distribution charts can be found below:

* The bar in red indicates where KDA Group's ROE % falls into.



KDA Group ROE % Calculation

KDA Group's annualized ROE % for the fiscal year that ended in Jul. 2025 is calculated as

ROE %=Net Income (A: Jul. 2025 )/( (Total Stockholders Equity (A: Jul. 2024 )+Total Stockholders Equity (A: Jul. 2025 ))/ count )
=-5.879/( (9.112+7.939)/ 2 )
=-5.879/8.5255
=-68.96 %

KDA Group's annualized ROE % for the quarter that ended in Jan. 2026 is calculated as

ROE %=Net Income (Q: Jan. 2026 )/( (Total Stockholders Equity (Q: Oct. 2025 )+Total Stockholders Equity (Q: Jan. 2026 ))/ count )
=-3.912/( (6.957+6.699)/ 2 )
=-3.912/6.828
=-57.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jan. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -57.29% mean?
KDA Group (KDAGF) has a ROE % of -57.29% as of Jan. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on KDA Group and its competitors. According to the industry distribution chart, KDA Group ranks #570 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 90.8%.
Is KDA Group's ROE % too high?
KDA Group's current ROE % is -57.29%. Based on the distribution chart, KDA Group ranks #570 out of 628 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does KDA Group's ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, KDA Group ranks #570 out of 628 companies for ROE %. This places KDA Group in the lower half of its industry. The industry median ROE % is 5.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on KDA Group and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KDA Group's current ROE % is -57.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDA Group stock overvalued right now?
KDA Group (KDAGF) has a current ROE % of -57.29%. The current ROE % is -57.29%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For KDA Group (KDAGF), the current ROE % is -57.29% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

KDA Group Business Description

Other Exchanges O1M:GermanyKDA:Canada
Address 1351 Notre-Dame East, Suite 300, Thetford Mines, QC, CAN, G6G 0G5
KDA Group Inc provides technological and operational efficiency solutions for general and specialized health sectors through its technology platform, which includes electronic prescription platforms for Canada and the United States and Adherize and Medherize functionalities for pharmaceutical adherence and oncology-focused therapeutic monitoring. The company operates through two segments: Pharmaceutical Technology and Corporate.